(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
0.87% $ 11.57
@ $11.60
Выпущен: 26 апр. 2024 @ 22:44
Доходность: -0.26%
Предыдущий сигнал: апр. 26 - 16:45
Предыдущий сигнал:
Доходность: 0.35 %
Live Chart Being Loaded With Signals
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets...
Stats | |
---|---|
Объем за сегодня | 3.79M |
Средний объем | 8.77M |
Рыночная капитализация | 13.74B |
EPS | $0 ( 2024-02-28 ) |
Дата следующего отчета о доходах | ( $0 ) 2024-05-06 |
Last Dividend | $0.120 ( 2023-11-22 ) |
Next Dividend | $0 ( N/A ) |
P/E | 231.40 |
ATR14 | $0.250 (2.16%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-18 | Le Goff Corinne | Buy | 110 162 | Restricted Stock Units |
2024-04-18 | Le Goff Corinne | Buy | 78 688 | Restricted Stock Units |
2024-04-15 | Le Goff Corinne | Buy | 0 | |
2024-04-02 | Malik Rajiv | Buy | 18 845 | Restricted Stock Units |
2024-03-13 | Mauro Anthony | Sell | 250 000 | Common Stock |
INSIDER POWER |
---|
9.39 |
Last 99 transactions |
Buy: 1 339 847 | Sell: 1 117 278 |
Объем Корреляция
Viatris Inc. Корреляция
10 Самые положительные корреляции | |
---|---|
MMAC | 0.897 |
NETE | 0.888 |
SRAC | 0.833 |
AMRB | 0.83 |
RAVN | 0.829 |
BRKH | 0.824 |
DOOO | 0.824 |
EUSG | 0.819 |
BOCH | 0.817 |
TKNO | 0.816 |
10 Самые отрицательные корреляции | |
---|---|
SVOK | -0.94 |
PAIC | -0.907 |
SVAC | -0.9 |
RMRM | -0.883 |
FEYE | -0.846 |
TLGT | -0.841 |
SPRT | -0.83 |
FTOCU | -0.823 |
FTOC | -0.815 |
OPCH | -0.808 |
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Viatris Inc. Корреляция - Валюта/Сырье
Viatris Inc. Финансовые показатели
Annual | 2023 |
Выручка: | $15.38B |
Валовая прибыль: | $6.57B (42.70 %) |
EPS: | $0.0456 |
FY | 2023 |
Выручка: | $15.38B |
Валовая прибыль: | $6.57B (42.70 %) |
EPS: | $0.0456 |
FY | 2022 |
Выручка: | $16.26B |
Валовая прибыль: | $6.50B (39.95 %) |
EPS: | $1.710 |
FY | 2021 |
Выручка: | $17.89B |
Валовая прибыль: | $5.58B (31.17 %) |
EPS: | $-2.11 |
Financial Reports:
No articles found.
Viatris Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.120 (N/A) |
$0.120 (N/A) |
$0.120 (N/A) |
$0.120 (N/A) |
$0.240 (N/A) |
$0.120 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.00741 | 1986-12-24 |
Last Dividend | $0.120 | 2023-11-22 |
Next Dividend | $0 | N/A |
Payout Date | 2023-12-15 | |
Next Payout Date | N/A | |
# dividends | 88 | -- |
Total Paid Out | $2.99 | -- |
Avg. Dividend % Per Year | 2.32% | -- |
Score | 5.02 | -- |
Div. Sustainability Score | 6.81 | |
Div.Growth Potential Score | 4.62 | |
Div. Directional Score | 5.72 | -- |
Year | Amount | Yield |
---|---|---|
1986 | $0.00741 | 0.28% |
1987 | $0.0148 | 0.88% |
1988 | $0.0111 | 0.86% |
1989 | $0.0148 | 1.13% |
1990 | $0.0222 | 0.63% |
1991 | $0.0296 | 1.01% |
1992 | $0.0326 | 0.53% |
1993 | $0.0416 | 0.46% |
1994 | $0.0564 | 0.78% |
1995 | $0.0652 | 0.85% |
1996 | $0.0712 | 0.70% |
1997 | $0.0712 | 0.97% |
1998 | $0.0712 | 0.80% |
1999 | $0.0712 | 0.53% |
2000 | $0.0712 | 0.66% |
2001 | $0.0712 | 0.65% |
2002 | $0.0756 | 0.47% |
2003 | $0.0966 | 0.61% |
2004 | $0.120 | 0.48% |
2005 | $0.210 | 1.20% |
2006 | $0.240 | 1.20% |
2007 | $0.120 | 0.60% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0.330 | 1.78% |
2022 | $0.480 | 3.38% |
2023 | $0.600 | 5.27% |
2024 | $0 | 0.00% |
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.00355 | 1.500 | 9.93 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.00115 | 1.200 | 9.96 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.00263 | 1.500 | -1.082 | -1.623 | [0.1 - 1] |
payoutRatioTTM | 10.52 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 1.572 | 0.800 | 7.14 | 5.71 | [1 - 3] |
quickRatioTTM | 0.658 | 0.800 | -0.833 | -0.666 | [0.8 - 2.5] |
cashRatioTTM | 0.128 | 1.500 | -0.401 | -0.602 | [0.2 - 2] |
debtRatioTTM | 0.382 | -1.500 | 3.63 | -5.45 | [0 - 0.6] |
interestCoverageTTM | 1.886 | 1.000 | -0.413 | -0.413 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.33 | 2.00 | 9.22 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.937 | 2.00 | 9.03 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.890 | -1.500 | 6.44 | -9.66 | [0 - 2.5] |
grossProfitMarginTTM | 0.419 | 1.000 | 6.36 | 6.36 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0708 | 1.000 | -0.585 | -0.585 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.154 | 1.000 | -0.257 | -0.257 | [0.2 - 2] |
assetTurnoverTTM | 0.323 | 0.800 | -1.178 | -0.943 | [0.5 - 2] |
Total Score | 6.81 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 253.84 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.00263 | 2.50 | -0.695 | -1.623 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.937 | 2.00 | 9.35 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.15 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.33 | 2.00 | 9.22 | 10.00 | [0 - 30] |
payoutRatioTTM | 10.52 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | -1.592 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.182 | 1.000 | 7.96 | 0 | [0.1 - 0.5] |
Total Score | 4.62 |
Viatris Inc.
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа